PGRPs activate the Toll or immune deficiency (IMD)/JNK pathways or induce proteolytic cascades that generate antimicrobial peptides (Gao et al., 2015; Chen et al., 2014). This evidence concerns the gene TLR4 and Immunodeficiency.